BeingabletogointoVR, youactuallyimmediatelygainnewinsights, sothiscouldsendyouon a completelynewpathofmoleculardevelopmentthatwould'veotherwiseneverbeendiscovered.
Evenwith a quickerpathtodiscovery, onlyaround 1 in 10 newantibioticsmakeitpastclinicaltrial, andnoantibioticdesignedwithNanome's platformisatthatstageyet.